CSE Bulletin: Reinstatement - Awakn Life Sciences Corp. (AWKN)
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Awakn Life Sciences Inks Licensing Partnership Deal With Oklahoma-based Clinic
Canadian Securities Exchange Reports February 2024 Performance Figures
CSE Bulletin: New Listing - Awakn Life Sciences Corp. (AWKN)
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
No Data
No Data